HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Congressional Supplement Scrutiny Won’t Take Front Seat ... Yet

This article was originally published in The Tan Sheet

Executive Summary

Key congressional health players' interest in food safety legislation fairly assures "serious action" on Senate food safety legislation within the next year, according to United Natural Products Alliance Senior Advisor Peter Reinecke

You may also be interested in...

FDA Analyzing Lead Levels In Multivitamins, Concerned About NDIs

FDA recently tested more than 300 multivitamins for lead and will publish the results in response to pressure from Capitol Hill to follow up on a 2007 report that at least one multivitamin marketed in the U.S. contained "dangerous levels" of lead

CRN Disputes FDA’s Interpretation Of Labeling Requirements In AER Law

The Council for Responsible Nutrition takes issue with FDA's suggested labeling requirements likely to be included in an industry guidance on the adverse reporting law for monograph OTCs and dietary supplements

Industry Cultivates Support In Congress To Add Supplements To Food Stamps

Legislation the House passed to reauthorize federal farm subsidy programs does not add multivitamins and other dietary supplements to food stamp coverage, but the Council for Responsible Nutrition expects progress this year in building congressional support for making the change

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts